Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1997 Jul;63(1):59–65. doi: 10.1136/jnnp.63.1.59

Apolipoprotein E ε4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence

V Jelic 1, P Julin 1, M Shigeta 1, A Nordberg 1, L Lannfelt 1, B Winblad 1, L Wahlund 1
PMCID: PMC2169641  PMID: 9221969

Abstract

OBJECTIVES—The ε4 allele of apolipoprotein E (APOE) represents a major biological risk factor for late onset Alzheimer's disease. However, it is still not known whether the APOE genotype affects the progression of the disease, assessed by different functional methods.
METHODS—The study sample included 41 patients with probable Alzheimer's disease. Subjects had similar severity of disease, age of onset, and duration of illness, and were subcategorised according to their APOE genotypes: 17 with no ε4 allele, 14 with one ε4 allele, and 10 with two ε4 alleles. The control group consisted of 18 healthy subjects comparable with the patients in age and education. Analysed quantitive EEG (qEEG) variables were the ratio of alpha and theta absolute power and EEG coherence in alpha frequency band, representing major cortical association pathways.
RESULTS—There was pronounced EEG slowing in all three patient subgroups compared with the controls for the alpha/theta ratio, but there was no significant difference across the patient subgroups. Patients homozygous for the APOE ε4 allele had reduced right and left temporoparietal, right temporofrontal, and left occipitoparietal coherence. Patients without and with one ε4 allele showed an overlap between the control group and group with two ε4 alleles in coherence measures.
CONCLUSIONS—APOE ε4 does not influence EEG slowing, an index which reflects severity of the disease in patients with Alzheimer's disease, but seems to be associated with selective decreases in functional connectivity as assessed by EEG coherence. This finding might be of clinical importance when considering different pathogenetic mechanisms.



Full Text

The Full Text of this article is available as a PDF (158.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert M. S., Duffy F. H., McAnulty G. B. Electrophysiologic comparisons between two groups of patients with Alzheimer's disease. Arch Neurol. 1990 Aug;47(8):857–863. doi: 10.1001/archneur.1990.00530080039008. [DOI] [PubMed] [Google Scholar]
  2. Basun H., Grut M., Winblad B., Lannfelt L. Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett. 1995 Jan 2;183(1-2):32–34. doi: 10.1016/0304-3940(94)11107-t. [DOI] [PubMed] [Google Scholar]
  3. Besthorn C., Förstl H., Geiger-Kabisch C., Sattel H., Gasser T., Schreiter-Gasser U. EEG coherence in Alzheimer disease. Electroencephalogr Clin Neurophysiol. 1994 Mar;90(3):242–245. doi: 10.1016/0013-4694(94)90095-7. [DOI] [PubMed] [Google Scholar]
  4. Bondi M. W., Salmon D. P., Monsch A. U., Galasko D., Butters N., Klauber M. R., Thal L. J., Saitoh T. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology. 1995 Dec;45(12):2203–2206. doi: 10.1212/wnl.45.12.2203. [DOI] [PubMed] [Google Scholar]
  5. Coben L. A., Danziger W. L., Berg L. Frequency analysis of the resting awake EEG in mild senile dementia of Alzheimer type. Electroencephalogr Clin Neurophysiol. 1983 Apr;55(4):372–380. doi: 10.1016/0013-4694(83)90124-4. [DOI] [PubMed] [Google Scholar]
  6. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E., Tanzi R. E. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology. 1995 Jul;45(7):1323–1328. doi: 10.1212/wnl.45.7.1323. [DOI] [PubMed] [Google Scholar]
  7. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  8. Dal Forno G., Rasmusson D. X., Brandt J., Carson K. A., Brookmeyer R., Troncoso J., Kawas C. H. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol. 1996 Apr;53(4):345–350. doi: 10.1001/archneur.1996.00550040085017. [DOI] [PubMed] [Google Scholar]
  9. De Lacoste M. C., White C. L., 3rd The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol Aging. 1993 Jan-Feb;14(1):1–16. doi: 10.1016/0197-4580(93)90015-4. [DOI] [PubMed] [Google Scholar]
  10. Dierks T., Perisic I., Frölich L., Ihl R., Maurer K. Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: relation to severity of dementia. Psychiatry Res. 1991 Nov;40(3):181–194. doi: 10.1016/0925-4927(91)90009-f. [DOI] [PubMed] [Google Scholar]
  11. Duffy F. H., Albert M. S., McAnulty G. Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Ann Neurol. 1984 Oct;16(4):439–448. doi: 10.1002/ana.410160404. [DOI] [PubMed] [Google Scholar]
  12. Feskens E. J., Havekes L. M., Kalmijn S., de Knijff P., Launer L. J., Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ. 1994 Nov 5;309(6963):1202–1206. doi: 10.1136/bmj.309.6963.1202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  14. Frisoni G. B., Calabresi L., Geroldi C., Bianchetti A., D'Acquarica A. L., Govoni S., Sirtori C. R., Trabucchi M., Franceschini G. Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia. 1994 Sep-Oct;5(5):240–242. doi: 10.1159/000106730. [DOI] [PubMed] [Google Scholar]
  15. Helkala E. L., Laulumaa V., Soininen H., Partanen J., Riekkinen P. J. Different patterns of cognitive decline related to normal or deteriorating EEG in a 3-year follow-up study of patients with Alzheimer's disease. Neurology. 1991 Apr;41(4):528–532. doi: 10.1212/wnl.41.4.528. [DOI] [PubMed] [Google Scholar]
  16. Hendricks H. T., Franke C. L., Theunissen P. H. Cerebral amyloid angiopathy: diagnosis by MRI and brain biopsy. Neurology. 1990 Aug;40(8):1308–1310. doi: 10.1212/wnl.40.8.1308. [DOI] [PubMed] [Google Scholar]
  17. Jelic V., Shigeta M., Julin P., Almkvist O., Winblad B., Wahlund L. O. Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. Dementia. 1996 Nov-Dec;7(6):314–323. doi: 10.1159/000106897. [DOI] [PubMed] [Google Scholar]
  18. Kuskowski M. A., Mortimer J. A., Morley G. K., Malone S. M., Okaya A. J. Rate of cognitive decline in Alzheimer's disease is associated with EEG alpha power. 1993 Apr 15-May 1Biol Psychiatry. 33(8-9):659–662. doi: 10.1016/0006-3223(93)90108-p. [DOI] [PubMed] [Google Scholar]
  19. Lehtovirta M., Soininen H., Helisalmi S., Mannermaa A., Helkala E. L., Hartikainen P., Hänninen T., Ryynänen M., Riekkinen P. J. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology. 1996 Feb;46(2):413–419. doi: 10.1212/wnl.46.2.413. [DOI] [PubMed] [Google Scholar]
  20. Leuchter A. F., Dunkin J. J., Lufkin R. B., Anzai Y., Cook I. A., Newton T. F. Effect of white matter disease on functional connections in the aging brain. J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1347–1354. doi: 10.1136/jnnp.57.11.1347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Leuchter A. F., Newton T. F., Cook I. A., Walter D. O., Rosenberg-Thompson S., Lachenbruch P. A. Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. Brain. 1992 Oct;115(Pt 5):1543–1561. doi: 10.1093/brain/115.5.1543. [DOI] [PubMed] [Google Scholar]
  22. Leuchter A. F., Spar J. E., Walter D. O., Weiner H. Electroencephalographic spectra and coherence in the diagnosis of Alzheimer's-type and multi-infarct dementia. A pilot study. Arch Gen Psychiatry. 1987 Nov;44(11):993–998. doi: 10.1001/archpsyc.1987.01800230073012. [DOI] [PubMed] [Google Scholar]
  23. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  24. Myers R. H., Schaefer E. J., Wilson P. W., D'Agostino R., Ordovas J. M., Espino A., Au R., White R. F., Knoefel J. E., Cobb J. L. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology. 1996 Mar;46(3):673–677. doi: 10.1212/wnl.46.3.673. [DOI] [PubMed] [Google Scholar]
  25. Newton T. F., Leuchter A. F., Walter D. O., Van Gorp W. C., Stern C. E., Mandelkern M., Weiner H. EEG coherence in men with AIDS: association with subcortical metabolic activity. J Neuropsychiatry Clin Neurosci. 1993 Summer;5(3):316–321. doi: 10.1176/jnp.5.3.316. [DOI] [PubMed] [Google Scholar]
  26. Penttilä M., Partanen J. V., Soininen H., Riekkinen P. J. Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. Electroencephalogr Clin Neurophysiol. 1985 Jan;60(1):1–6. doi: 10.1016/0013-4694(85)90942-3. [DOI] [PubMed] [Google Scholar]
  27. Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniemi A., Niinistö L., Halonen P., Kontula K. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med. 1995 Nov 9;333(19):1242–1247. doi: 10.1056/NEJM199511093331902. [DOI] [PubMed] [Google Scholar]
  28. Reiman E. M., Caselli R. J., Yun L. S., Chen K., Bandy D., Minoshima S., Thibodeau S. N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med. 1996 Mar 21;334(12):752–758. doi: 10.1056/NEJM199603213341202. [DOI] [PubMed] [Google Scholar]
  29. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  30. Scheltens P., Barkhof F., Valk J., Algra P. R., van der Hoop R. G., Nauta J., Wolters E. C. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain. 1992 Jun;115(Pt 3):735–748. doi: 10.1093/brain/115.3.735. [DOI] [PubMed] [Google Scholar]
  31. Soininen H., Partanen J., Laulumaa V., Päkkönen A., Helkala E. L., Riekkinen P. J. Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome. Electroencephalogr Clin Neurophysiol. 1991 Nov;79(5):342–348. doi: 10.1016/0013-4694(91)90198-d. [DOI] [PubMed] [Google Scholar]
  32. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wisniewski T., Lalowski M., Golabek A., Vogel T., Frangione B. Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet. 1995 Apr 15;345(8955):956–958. doi: 10.1016/s0140-6736(95)90701-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES